Pharmaceutical Cluster

In 2010, several pharmaceutical companies teamed up in the Ural Pharmaceutical Cluster Non-Commercial Partnership. In 2012 the name was changed to Ural Biomedical Cluster Non-Commercial Partnership.

OOO Zavod Medsintez, the main resident, and  BayerHealthCare are developing new production capacities through a strategic cooperation.

The most important and prominent projects:

    • production of active pharmaceutical ingredients and finished dosage forms of recombinant human insulin Rosinsulin®;
    • production of active pharmaceutical ingredients and finished dosage forms of antiviral drugs, e.g. an innovative domestic medication Triazavirin based on a new original molecule;
    • modernisation and expansion of production operations for a new hemodialysis system Malakhit, automated water treatment units for hemodialysis, thermal and ozone disinfection modules and bicarbonate cartridges for dialysis;
    • modernisation and expansion of production operations for infusion, peritoneal solutions and technologies for hemodialysis.
Source: PWC Investment Guide and Zavod Medsintez